Aeromics, Inc.
✓ AI-Ready Profile83
AI Score
🤖 AI-Optimized Summary
Aeromics, Inc. is a clinical-stage pharmaceutical company developing an intravenously administered aquaporin-4 (AQP4) inhibitor (AER-271) for severe, acute ischemic stroke that will prevent or arrest brain swelling (cerebral edema) following an ischemic event.
📋 Business Details
Is this your business?
Claim this profile to improve your AI Visibility Score and get verified.
Claim My AI Profile →